Mutational Profiling of Korean Lymphomas and Diffuse Large B-Cell Lymphoma Subtype Classification Using Targeted...

Area of Science:

• Hematological Oncology
• Molecular Genetics
• Genomic Medicine

Background:

• Lymphoma is a complex hematological malignancy requiring precise diagnosis for effective treatment.
• Molecular genetic testing offers valuable insights into lymphoma's diverse characteristics.
• Understanding the genetic landscape in specific populations, like Koreans, is crucial.

Purpose of the Study:

• To investigate the genetic profiles of Korean lymphoma patients.
• To evaluate the utility of a next-generation sequencing (NGS)-based targeted panel for lymphoma mutational analysis.

Main Methods:

• A targeted panel sequencing approach was employed, covering 588 clinically relevant genes.
• The study analyzed 34 formalin-fixed paraffin-embedded lymphoma samples from Korean patients.

Main Results:

• Diffuse large B-cell lymphoma (DLBCL) was the most prevalent subtype identified.
• TP53, MYD88, CD79B, FOXO1, KMT2D, TNFRSF14, and TET2 were among the frequently mutated genes.
• Genetic subtype classification algorithms were applied to DLBCL cases, successfully categorizing a portion into specific subtypes.

Conclusions:

• Targeted panel sequencing is effective for revealing lymphoma mutational profiles in clinical samples.
• The study provides initial insights into the mutational landscape of lymphomas within the Korean population, with a focus on DLBCL.